HRT · Estradiol patch
Minivelle patch: doses, use, and how it compares to other estradiol patches.
The Minivelle patch is a small, discreet, twice-weekly transdermal estradiol option — favored by women who want lower blood-clot risk than oral estrogen without the size or adhesive issues of older patches. Here is the clinician-reviewed guide.
What Minivelle is
Minivelle is an FDA-approved matrix transdermal patch containing bioidentical 17β-estradiol. It is manufactured by Noven and marketed for menopause hormone therapy. It is a "twice-weekly" patch: one patch is worn for 3–4 days, then replaced.
Minivelle doses (delivered per day)
- 0.025 mg/day — low dose. First-line for many women.
- 0.0375 mg/day — low-to-standard.
- 0.05 mg/day — standard dose. Most commonly prescribed.
- 0.075 mg/day — above-standard.
- 0.1 mg/day — highest FDA-approved dose.
What Minivelle treats
- Moderate-to-severe hot flashes and night sweats.
- Vulvovaginal atrophy (dryness, painful intercourse).
- Prevention of postmenopausal osteoporosis.
- Symptomatic estrogen deficiency in premature ovarian insufficiency and surgical menopause.
How to apply the Minivelle patch
- Choose clean, dry, non-irritated skin on the lower abdomen (never the breasts).
- Peel and apply immediately; press firmly for 10 seconds.
- Replace every 3–4 days (twice weekly). Rotate sites to avoid irritation.
- You can shower, swim, and exercise with the patch on.
- If a patch falls off, reapply the same one or use a new one and continue on schedule.
Minivelle vs other estradiol patches
- Minivelle vs Vivelle-Dot — same manufacturer, same active ingredient, same doses. Minivelle is smaller (about half the surface area). Efficacy equivalent.
- Minivelle vs Climara — Climara is a once-weekly patch. Minivelle is twice-weekly. Preference varies by adhesion and skin sensitivity.
- Minivelle vs Alora — Alora is another twice-weekly matrix patch; both are similar in dosing and efficacy.
- Minivelle vs oral estradiol — patches bypass the liver, lowering VTE, stroke, and gallbladder risk. NAMS 2022 prefers transdermal delivery for higher-risk women.
Safety profile
Transdermal estradiol has a favorable safety profile compared to oral estrogens: lower VTE, stroke, and gallbladder disease risk. Contraindications include personal history of breast cancer, active VTE, unexplained vaginal bleeding, and severe liver disease.
How to get Minivelle through Kindr
Complete a Kindr menopause intake. A board-certified clinician licensed in your state will review, and if Minivelle (or a generic equivalent) is appropriate, ship the prescription from a licensed U.S. pharmacy. Available in all 50 states.
Frequently asked questions
What is the Minivelle patch?
Minivelle is an FDA-approved twice-weekly transdermal estradiol patch — the smallest estradiol patch on the U.S. market. It delivers bioidentical 17β-estradiol through the skin at doses of 0.025, 0.0375, 0.05, 0.075, or 0.1 mg per day and is used to treat moderate-to-severe hot flashes, night sweats, vulvovaginal atrophy, and to prevent postmenopausal osteoporosis.
How is Minivelle applied?
Apply one patch to clean, dry skin on the lower abdomen (not the breasts) twice a week — every 3 to 4 days. Rotate application sites. The patch is water-resistant and can be worn while showering, swimming, or exercising.
What are Minivelle doses?
Minivelle is available in five strengths delivered per day: 0.025 mg (low), 0.0375 mg (low-to-standard), 0.05 mg (standard), 0.075 mg (above-standard), and 0.1 mg (highest). Most patients start at 0.025 or 0.05 mg/day and titrate to symptom response at 6–12 weeks.
What is the difference between Minivelle and Vivelle-Dot?
Both are twice-weekly bioidentical estradiol matrix patches from the same manufacturer. Minivelle patches are significantly smaller (about half the size), which many women find more discreet and comfortable. Clinical efficacy at equivalent doses is identical.
Is there a generic for the Minivelle patch?
A directly bioequivalent Minivelle-branded generic is limited, but generic estradiol transdermal patches (matrix, twice-weekly) at the same strengths are available and interchangeable at most pharmacies. Ask your Kindr clinician for the most cost-effective option.
What are the side effects of Minivelle?
Most common: application-site redness or itching, breast tenderness, headache, and (for women with a uterus taking a progestogen) irregular spotting in the first 3–6 months. Serious risks — blood clots, stroke, breast cancer — are lower with transdermal delivery than with oral estrogen.
Do I need progesterone with the Minivelle patch?
Yes, if you still have a uterus. Any systemic estradiol dose requires a progestogen (Prometrium is most common) to protect the uterine lining. Women who have had a hysterectomy can use Minivelle alone.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.